Free Deal Calculator

Calculate Therapeutic Vaccine Deal Values Instantly

Get market-validated licensing valuations for non-mRNA therapeutic vaccines with real-time deal comparables and premium positioning.

Calculate Now

Market-Leading Premium Accuracy

Our calculator incorporates the 15% valuation premium for therapeutic vaccines, ensuring you capture the full market value of your non-mRNA assets.

Real-Time Deal Benchmarking

Access live data from $60M-$250M Phase 2 upfront payments and total deal values up to $2.5B for accurate market positioning.

Instant Professional Reports

Generate boardroom-ready valuation reports in minutes, not weeks. Perfect for term sheet negotiations and investor presentations.

$2.5B

Max Deal Values Tracked

15%

Vaccine Premium Applied

$250M

Top Phase 2 Upfronts

500+

Deals Analyzed

How It Works

Input Vaccine Details

Enter your therapeutic vaccine's indication, development stage, and key differentiators

Apply Market Premiums

Our algorithm automatically applies the 15% therapeutic vaccine premium to baseline valuations

Get Deal Structure

Receive detailed upfront, milestone, and royalty recommendations based on current market data

Frequently Asked Questions

How does the 15% therapeutic vaccine premium work?

Our calculator automatically applies a 15% valuation premium to baseline licensing terms, reflecting the market's recognition of therapeutic vaccines' unique value proposition compared to traditional modalities.

What deal sizes can I expect for Phase 2 therapeutic vaccines?

Current market data shows Phase 2 therapeutic vaccine upfronts ranging from $60M to $250M, with total deal values between $700M and $2.5B depending on indication and competitive landscape.

Does this cover all therapeutic vaccine types except mRNA?

Yes, our calculator covers protein subunit, viral vector, peptide-based, and other non-mRNA therapeutic vaccine platforms with indication-specific adjustments.

How current is the licensing data used in calculations?

Our database is updated quarterly with the latest therapeutic vaccine licensing deals, ensuring your valuations reflect current market conditions and recent transaction premiums.

Ready to Calculate Your Deal Terms?

Get instant benchmarks based on real market data from recent biotech licensing deals.

Start Calculating